Glycoprotein 120 polymorphism in an HIV type 1 epidemic originating from a point source: Nucleotide sequence analysis of variants with conserved V3 loop sequences

AIDS Research and Human Retroviruses

Volumn 12, Issue 3, 1996, Pages 251-253

  Bobkov, Aleksei ^a   Cheingsong Popov, Rachanee ^b   Garaev, Mansur ^a   Weber, Jonathan ^b  

^a D I IVANOVSKY INSTITUTE OF VIROLOGY   (Russian Federation)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN GP 120;

CLINICAL ARTICLE; EPIDEMIC; GENETIC POLYMORPHISM; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; NOTE; NUCLEOTIDE SEQUENCE; PHYLOGENY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; USSR; VIRUS GENOME; VIRUS ISOLATION; VIRUS TRANSMISSION;

EID: 0030019609     PISSN: 08892229     EISSN: None     Source Type: Journal    
DOI: 10.1089/aid.1996.12.251     Document Type: Note

References (9)

1. Bobkov A, Garaev MM, Rzhaninova A, Kaleebu P, Pitman R, Weber JN, and Cheinsong-Popov R: Molecular epidemiology of HIV-1 in the former Soviet Union: Analysis of env V3 sequences and their correlation with epidemiological data. AIDS 1994;8:619-624.
2. Pokrovsky VV, Eramova IU, and Deulina MO: Outbreak of hospital infection caused by human immunodeficiency virus (HIV) in Elista (in Russian). Z Microbiol Epidemiol Immunobiol 1990;4:17-23.
3. Cheingsong-Popov R, Bobkov A, and Garaev M: Identification of human immunodeficiency virus type I subtypes and their distribution in the Commonwealth of Independent States (former Soviet Union) by serologic V3 peptide-binding assays and V3 sequence analysis. J Infect Dis 1993;168:292-297.
4. Felsenstein J: PHYLIP - phylogenetic interference package (version 3.2). Cladistics 1989;5:164-166.
5. Javaherian KA, Langlois AJ, McDanal C, Ross KL, Eckler LI, Jellis CL, Profy AT, Rusche JR, Bolognesi DP, Putney SD, and Matthews TJ: Principal neutralizing domain of the human immunodeficiency virus type 1 envelope protein. Proc Natl Acad Sci USA 1989;86:6768-6772.
6. Palker TJ, Clark ME, Langlois AJ, Matthews TJ, Weinhold KJ, Randall RR, Bolognesi DP, and Haynes BF: Type-specific neutralization of the human immunodeficiency virus with antibodies to env-encoded synthetic peptides. Proc Natl Acad Sci USA 1988;85:1932-1936.
7. Fung MSC, Sun CRY, Gordon WL, Liou RS, Chang TW, Sun WNC, Daar ES, and Ho DD: Identification and characterization of a neutralization site within the second varible region of human immunodeficiency virus type 1 gp120. J Virol 1992;66:848-856.
8. Moore JP and Ho DD: Antibodies to discontinuous or conformationally sensitive epitopes on the gp120 glycoprotein of human immunodeficiency virus type 1 are highly prevalent in sera of infected humans. J Virol 1993;67:863-975.
9. Nara P, Dunlop N, Waters D, Smit L, Goudsmit J, and Gallo RC: Serological and molecular analysis of the immunodominant loop (a.a.296-331) from neutralization resistant variants derived from HIV-1 HTLV-IIIB inoculated chimpanzees. V International Conference on AIDS, Montreal, June 1989. [Abstract T.C.O. 22]